MARKET

PRTC

PRTC

Puretech Health
NASDAQ
33.39
0.00
0.00%
Closed 16:00 02/03 EST
OPEN
33.39
PREV CLOSE
33.39
HIGH
33.39
LOW
33.39
VOLUME
203
TURNOVER
130
52 WEEK HIGH
43.57
52 WEEK LOW
18.15
MARKET CAP
931.01M
P/E (TTM)
-71.3462
1D
5D
1M
3M
1Y
5Y
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/20 18:24
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 01/18 18:25
PureTech Health (PRTC) Investor Presentation - Slideshow
Seeking Alpha · 01/11 18:57
PureTech Health Plc Reports On The Key Progress Made Across Its Wholly Owned Programs And Founded Entities In 2022
Benzinga · 12/22/2022 09:42
BRIEF-PureTech's LYT-300 Demonstrates Oral Bioavailability, Tolerability And GABAA Receptor Target Engagement
Reuters · 12/19/2022 12:15
PureTech's LYT-300 Demonstrates Oral Bioavailability, Tolerability And GABAA Receptor Target Engagement In Healthy Volunteers
Benzinga · 12/19/2022 12:11
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
BOSTON, December 13, 2022--PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
Business Wire · 12/13/2022 12:00
BRIEF-PureTech Presents Data For Blood Cancer Drug At ASH Annual Meeting
Reuters · 12/12/2022 15:14
More
About PRTC
PureTech Health plc (PureTech) is a biotherapeutics company engaged in the treatment paradigm for devastating diseases. The Company has created a pipeline through its experienced research and development team and its network of scientists, clinicians, and industry leaders. The pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both United States (U.S.) Food and Drug Administration (FDA) clearance and European marketing authorization. All of the underlying programs and platforms that resulted in the pipeline of therapeutic candidates are identified or discovered and then advanced by the PureTech team through key validation points based on insights in immunology and drug development. The Company's wholly owned pipeline consists of various programs, including LYT-100, LYT-200, LYT-210, LYT-300, LYT-500, LYT-510, and LYT-503/IMB-150.

Webull offers kinds of PureTech Health PLC (ADR) stock information, including NASDAQ:PRTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRTC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRTC stock methods without spending real money on the virtual paper trading platform.